Breaking Stories

Dementia expert says evidence behind Biogen Alzheimer’s drug ‘wasn’t sufficient’ for FDA approval

“Desperation should drive funding for Alzheimer’s research, it should not drive the interpretation of scientific evidence,” Karlawish said.

What's your reaction?

Excited
0
Happy
0
In Love
0
Not Sure
0
Silly
0

You may also like

Leave a reply

Your email address will not be published. Required fields are marked *